News

Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey
Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...
NBC New York28d
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
COPENHAGEN, Denmark — The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss ...
NBC 10 Philadelphia28d
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
COPENHAGEN, Denmark — The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight ...